Skip to main content
Clinical Trials/NCT06055855
NCT06055855
Completed
Not Applicable

A Randomized Controlled Trial Evaluating the Efficacy of Conventional Two-Needle Arthrocentesis Versus Surgery-Guided Arthrocentesis in the Management of Temporomandibular Joint Disorders

Marmara University1 site in 1 country20 target enrollmentSeptember 10, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Temporomandibular Joint Disorders
Sponsor
Marmara University
Enrollment
20
Locations
1
Primary Endpoint
Total Duration of Arthrocentesis Procedure
Status
Completed
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to compare two methods of arthrocentesis in treating temporomandibular joint (TMJ) disorders. The main questions it aims to answer are:

Is surgery-guided arthrocentesis more efficient in terms of operation time compared to traditional two-needle arthrocentesis? Does the use of surgical guides lead to less postoperative pain and better patient comfort?

Participants will:

Undergo either the traditional two-needle arthrocentesis or the surgery-guided arthrocentesis.

Be monitored for operation time, postoperative pain, and overall patient comfort.

Researchers will compare the outcomes of patients who underwent traditional two-needle arthrocentesis with those who had surgery-guided arthrocentesis to see if the latter can shorten operation time and improve patient comfort.

Registry
clinicaltrials.gov
Start Date
September 10, 2023
End Date
February 10, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ferit Bayram

Principal Investigator

Marmara University

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with Wilkes stage II, III, or IV Temporomandibular Joint (TMJ) internal derangement.
  • Presence of pain, sound, or both in the TMJ.
  • Limitation or locking in mouth opening, or both.
  • Patients who have not responded to symptoms after a minimum of three months of splint therapy.

Exclusion Criteria

  • Presence of infection in the puncture area.
  • Presence of osteomyelitis in the neighboring region.
  • Patients with uncontrolled coagulopathies.
  • Patients experiencing limitation in maximum mouth opening without disk disorder.
  • Patients with severe degenerative joint disease (e.g., deformed condylar contour, osteophyte findings in MRI).
  • History of TMJ surgery.
  • History of muscle-originated mandibular hypomobility.

Outcomes

Primary Outcomes

Total Duration of Arthrocentesis Procedure

Time Frame: Immediately following the completion of each arthrocentesis procedure, anticipated to occur on the day of the surgery.

he primary outcome measure of the study is the total time duration required to complete the arthrocentesis procedure. This duration will be measured from the time local anesthesia is administered to the time when the arthrocentesis is completed. In addition, the number of intraoperative repositions of the needles will also be recorded.

Secondary Outcomes

  • Volume of Ringer's Solution Used for Joint Irrigation(Immediately following the completion of each arthrocentesis procedure, anticipated to occur on the day of the surgery.)
  • Change in Postoperative Pain(7 days)
  • Change in Mouth Opening(7 days)
  • Change in Facial Swelling(7 days)

Study Sites (1)

Loading locations...

Similar Trials